Clinical trial
Antenatal Allopurinol in Intrauterine Growth Restriction
NCT00346463 · UMC Utrecht, Other · Unknown status
Key facts
| NCT number | NCT00346463 |
|---|---|
| Title | Antenatal Allopurinol in Intrauterine Growth Restriction |
| Official title | Does Antenatal Allopurinol Administration Improve Maternal and Neonatal Outcome in Intrauterine Growth Restriction? |
| Lead sponsor | UMC Utrecht, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Fetal Growth Retardation |
| Intervention type | Drug |
| Interventions | Allopurinol |
| Enrollment | 50 |
| Start date | Jul 1, 2006 |
| Completion | Jul 1, 2013 |
| First posted | Jun 30, 2006 |
| Last update posted | Apr 28, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: